Literature DB >> 12377167

Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.

Philippe Millet1, Christophe Graf, Alfred Buck, Bernard Walder, Vicente Ibáñez.   

Abstract

Recently, reference tissue methods have been proposed to estimate binding potential from PET data. A reference region without specifically bound ligand is used as an indirect input function to enable the expression of the time-concentration curve of a region of interest using a compartment model. However, PET dopaminergic and serotoninergic studies have shown differences between binding potential (BP) values obtained with reference tissue methods and those obtained with conventional kinetic modeling using an arterial input function. In this study, we measured the BP values for the benzodiazepine receptors in seven subjects using PET [(11)C]flumazenil and SPECT [(123)I]iomazenil radioligands. We compared the BP values obtained using the reference tissue methods with those obtained using the conventional kinetic method. These values were also compared with the absolute value of receptor density, B'(max). For the PET studies, a multi-injection approach employing labeled and unlabeled flumazenil was used to estimate the main binding parameters, BP and B'(max). For SPECT studies, a single injection protocol of [(123)I]iomazenil was used to estimate BP values. The BP values were estimated using one- and two-tissue compartment models for the target region. Similar BP values were obtained using either the one- or two-tissue compartment model. This is probably due to the rapid equilibrium between tissue compartments reached with these radioligands. For PET and SPECT, these BP values were highly correlated (r > 0.960) to the BP values obtained using the arterial input function. We also found high correlations between the BP values obtained using the simplified reference tissue method and the receptor density parameter B'(max) (r > 0.884). However, the reference tissue methods yielded lower BP values than those obtained using the conventional approach. Moreover, there was a bias on BP values that was not a simple scaling. It seems that the physiological values found in gray matter structures using these radioligands give acceptable BP values. We conclude that the reference tissue methods should be carefully evaluated for each radioligand.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377167

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  16 in total

Review 1.  Imaging the role of GABA in movement disorders.

Authors:  Henning Boecker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

2.  Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

Authors:  David Elmenhorst; Philipp T Meyer; Andreas Matusch; Oliver H Winz; Karl Zilles; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-23       Impact factor: 9.236

3.  Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.

Authors:  Yun Zhou; Susan M Resnick; Weiguo Ye; Hong Fan; Daniel P Holt; William E Klunk; Chester A Mathis; Robert Dannals; Dean F Wong
Journal:  Neuroimage       Date:  2007-03-16       Impact factor: 6.556

4.  External awareness and GABA--a multimodal imaging study combining fMRI and [18F]flumazenil-PET.

Authors:  Christine Wiebking; Niall W Duncan; Pengmin Qin; Dave J Hayes; Oliver Lyttelton; Paul Gravel; Jeroen Verhaeghe; Alexey P Kostikov; Ralf Schirrmacher; Andrew J Reader; Malek Bajbouj; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2012-09-21       Impact factor: 5.038

5.  Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study.

Authors:  Jee In Kang; Hae-Jeong Park; Se Joo Kim; Kyung Ran Kim; Su Young Lee; Eun Lee; Suk Kyoon An; Jun Soo Kwon; Jong Doo Lee
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

6.  Kinetic modelling of [11C]flumazenil using data-driven methods.

Authors:  Isabelle Miederer; Sibylle I Ziegler; Christoph Liedtke; Mary E Spilker; Matthias Miederer; Till Sprenger; Klaus J Wagner; Alexander Drzezga; Henning Boecker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-29       Impact factor: 9.236

7.  Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.

Authors:  Dieter Ory; Andrey Postnov; Michel Koole; Sofie Celen; Bart de Laat; Alfons Verbruggen; Koen Van Laere; Guy Bormans; Cindy Casteels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-01       Impact factor: 9.236

8.  The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates.

Authors:  John R Atack; Wai-Si Eng; Ray E Gibson; Christine Ryan; Barbara Francis; Bindi Sohal; Gerard R Dawson; Richard J Hargreaves; H Donald Burns
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

9.  [(18)F]FDG PET Neuroimaging Predicts Pentylenetetrazole (PTZ) Kindling Outcome in Rats.

Authors:  Pablo Bascuñana; Julián Javela; Mercedes Delgado; Rubén Fernández de la Rosa; Ahmed Anis Shiha; Luis García-García; Miguel Ángel Pozo
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

10.  Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome.

Authors:  Alicja Lerner; Anto Bagic; Janine M Simmons; Zoltan Mari; Omer Bonne; Ben Xu; Diane Kazuba; Peter Herscovitch; Richard E Carson; Dennis L Murphy; Wayne C Drevets; Mark Hallett
Journal:  Brain       Date:  2012-05-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.